Download presentation
Presentation is loading. Please wait.
Published byLouise O’Brien’ Modified over 9 years ago
1
Reminder: Class Housestaff tomorrow 1 st -2C, 2 nd - 2031, 3 rd - 3302 Board review take-home quiz due 8am Monday You may email your answers or place them in our box Compliance due by 8am Monday Log clinics and have PREP questions completed for August Sept Board Review is 15 days away… study your endocrine!
3
Generalized vasculitis Preferential to coronary arteries Genetic predisposition Possible infectious trigger Highest incidence in Asians, especially Japanese Median age 2y/o 75% < 5y/o
9
Least common feature Unilateral, anterior cervical triangle, >=1.5cm Firm, nontender, no overlying erythema
10
Fever is high spiking and remitting Polyarthritis/arthralgia Occurs within first week GI complaints Hydrops of gallbladder Hepatomegaly and jaundice Aseptic meningitis in 50%
13
IVIG 2g/kg Aspirin High dose (100mg/kg/d) at least 14 days Low dose (5mg/kg/d) ▪ May discontinue at 6 to 8 wks if normal coronaries Give influenza vaccine Defer measles and varicella vaccine for 11mos after IVIG
14
Age < 6mos Fever lasting 7 days Elevated acute phase reactants Get echo even in absence of other signs
15
10% fail to respond to initial IVIG Fever after 36hrs Re-administer IVIG IVIG refractory Kawasaki Disease Persistent fevers or elevated inflammatory markers despite 2 courses of IVIG
16
Virtually all deaths are cardiac Peak mortality at 2 to 6 weeks Myocardial Infarction may occur years later
17
Coronary artery aneurysms in 25% if untreated 50% Resolution of aneurysms 1 to 2 years after disease onset Echocardiography at diagnosis, 2 and 6 wks Treatment and activity individualized according to risk level
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.